No profile data available.
Roopa Industries Limited (ROOPAIND.BO) is a healthcare company in the drug manufacturing contractors industry, based in Hyderabad, India, with about 56 full-time employees.
It reported revenue of 1.21 billion INR for fiscal year 2025, and net income of 20.35 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 335.43 million INR, up 9.1% from a year before. Its market capitalization was 386.04 million INR as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 8, 2026.
Roopa Industries Limited manufactures, markets, and sells bulk drugs, intermediaries, and fine chemicals in India and internationally. The company offers triphenylphosphine, abacavir sulphate, d-penicillamine, s-octabase, DCC, and DPA 3, etc. It also manufactures and exports glucosamine salts. It serves pharma industry.
Roopa Industries reported 1.21 billion INR in revenue for fiscal year 2025. In Q3 2026 revenue was 335.43 million INR.
386.04 million INR as of October 8, 2026.
Listed companies of a similar size in the same industry (drug manufacturing contractors) include Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.NS), ANG Lifesciences India Limited (ANG.BO), Mangalam Drugs & Organics Limited (MANGALAM.NS), Medi-Caps Limited (MEDICAPQ.BO).